David A. Fiellin MD

Professor of Medicine (General Medicine), of Faculty of Arts and Sciences and of Public Health (Health Policy); Professor, Investigative Medicine; Director, Community Research and Implementation Core, Center for Interdisciplinary Research on AIDS (CIRA)


Departments & Organizations

Yale Medical Group

Office of Student Research

DAHRSSBIRT Training in Yale Residency ProgramsSchool of Public Health: Center for Interdisciplinary Research on AIDSInternal Medicine: General Internal Medicine: Primary Care Center, Yale-New Haven Hospital, Addiction Medicine; play2PREVENTSubstance Abuse Research | Psychotherapy Development Center

Research Interests

Substance abuse treatment in primary care; Emergency department and HIV specialty settings opioid agonist treatment with buprenorphine; Pharmacologic treatment of alcohol


Clinical Interests

Primary care; general internal medicine; addiction medicine


Education

  • B.A., Earlham College , 1983
  • M.D., Emory University , 1991

Selected Publication

  • Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O’Connor PG. Primary care–based buprenorphine taper vs maintenance therapy for prescription opioid dependence a randomized clinical trial. JAMA Internal Medicine 2014; 174(12): 1947-1954. PMID: 25330017

Latest Honor and Recognition

  • Nyswander/Dole Award(2006) , American Association for the Treatment of Opioid Dependence